Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1256071

Platinum Investment Management Ltd

Asset managerFiled 2026-08-13 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$406.7M
Reported positions
85
Top holdings a year, 3 yrs
+15.8%
Average holding period
5.9 yrs

Platinum Investment Management Ltd is an asset manager that reported 85 positions worth $406.7M in its Q2 2026 13F, filed 2026-08-13. Its largest holdings were Zto Express Cayman Inc (ZTO, 11.0%), Micron Technology Inc (MU, 5.0%), Lam Research Corp (LRCX, 4.9%). A portfolio copying its top holdings returned 15.8% a year over the last 3 years, against 20.4% for the S&P 500.

Platinum Investment Management Ltd holdings largest 50 of 85 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Platinum Investment Management Ltd 13F holdings
Stock% of 13F valueShare changeReported value
ZTOZto Express Cayman Inc11.0%+0.0%$44.6M
MUMicron Technology Inc5.0%-24.8%$20.5M
LRCXLam Research Corp4.9%+0.0%$20.1M
TCOMTrip Com Group Ltd3.4%-7.3%$14.0M
DDLDingdong Cayman Ltd3.1%+0.0%$12.5M
NOAHNoah Holdings Ltd-Spon Ads2.4%+0.0%$9.9M
AVGOBroadcom Inc2.4%+0.0%$9.9M
BIRKBirkenstock Holdings2.2%-23.6%$9.0M
AZNAstrazeneca PLC Ord2.2%+0.0%$9.0M
GOOGAlphabet Inc2.1%+0.0%$8.7M
MRKMerck & Co. Inc2.0%+0.0%$8.1M
APGEApogee Therapeutics Inc1.9%+0.0%$7.7M
ABBVAbbvie Inc1.9%+0.0%$7.6M
JNJJohnson & Johnson1.7%+0.0%$7.1M
YUMYum Brands Inc1.6%+0.0%$6.4M
PDDPdd Holdings Inc1.5%+0.0%$6.0M
COGTCogent Biosciences Inc1.5%+37.6%$6.0M
UBSUbs Group AG1.4%+0.0%$5.8M
NVDANvidia Corporation Com1.4%+0.0%$5.6M
IMVTImmunovant Inc1.4%-20.4%$5.6M
ARWRArrowhead Pharmaceuticals in1.3%+0.0%$5.3M
IDYAIdeaya Biosciences Inc1.3%+51.4%$5.2M
IQVIqvia Holdings Inc1.3%+0.0%$5.2M
HTHTH World Group Ltd1.2%+0.0%$4.9M
VERAVera Therapeutics Inc1.2%+0.0%$4.9M
GPCRStructure Therapeutics Inc1.2%+35.1%$4.8M
VVisa Inc Com Cl A1.2%-6.7%$4.8M
CATCaterpillar Inc Com1.2%-47.1%$4.8M
RCIRogers Communications Inc1.2%+0.0%$4.8M
ASAmer Sports Inc1.2%-6.7%$4.7M
KRThe Kroger Co1.1%+33.9%$4.5M
KLACKla Corp1.1%—$4.4M
CCJCameco Corp Com1.1%+0.0%$4.3M
AMDAdvanced Micro Devices Inc1.0%—$4.2M
RCUSArcus Biosciences Inc.1.0%+0.0%$4.1M
ADBEAdobe Inc0.9%+0.0%$3.8M
FNDFloor & Decor Hldgs Inc0.9%-7.4%$3.7M
METAMeta Platforms Inc Class A0.9%—$3.7M
PALIPalisade Bio Inc0.9%—$3.6M
BROSDutch Bros Inc0.9%—$3.6M
FICOFair Isaac Corp0.9%-11.8%$3.6M
GEVGe Vernova Inc0.9%—$3.6M
HDHome Depot Inc Com0.9%-13.0%$3.5M
VALValaris Ltd0.8%+0.0%$3.3M
ELFe.l.f. Beauty0.8%-37.9%$3.3M
CAVACava Group Inc0.8%-6.7%$3.3M
24477V105Definium Therapeutics Inc0.8%—$3.3M
ROIVRoivant Sciences Ltd0.8%—$3.3M
TRUTransunion0.8%+0.0%$3.2M
RVMDRevolution Medicines Inc0.8%—$3.2M

What Platinum Investment Management Ltd bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+31.3% /yr
S&P 500 +20.1%
3 years
+15.8% /yr
S&P 500 +20.4%
5 years
+9.2% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$406.7M85
Q1 2026$396.8M89
Q4 2025$432.7M124
Q3 2025$1.5B120
Q2 2025$1.5B115
Q1 2025$1.7B115
Q4 2024$1.7B115
Q3 2024$2.2B122
Q2 2024$2.5B134
Q1 2024$2.5B139
Q4 2023$2.5B142
Q3 2023$2.6B144

Questions about Platinum Investment Management Ltd's portfolio

What stocks does Platinum Investment Management Ltd own?

Platinum Investment Management Ltd's latest 13F, for Q2 2026 and filed Aug 13, 2026, lists 85 positions worth $406.7M. The largest are Zto Express Cayman Inc (ZTO) at 11.0%, Micron Technology Inc (MU) at 5.0%, Lam Research Corp (LRCX) at 4.9%, Trip Com Group Ltd (TCOM) at 3.4% and Dingdong Cayman Ltd (DDL) at 3.1%.

What did Platinum Investment Management Ltd buy last quarter?

In Q2 2026, Platinum Investment Management Ltd added Ideaya Biosciences Inc (IDYA) (+51.4% shares), Cogent Biosciences Inc (COGT) (+37.6% shares) and Structure Therapeutics Inc (GPCR) (+35.1% shares), compared with its Q1 2026 filing.

What did Platinum Investment Management Ltd sell last quarter?

In Q2 2026, Platinum Investment Management Ltd cut from its top 50 Terns Pharmaceuticals Inc (TERN), cut from its top 50 Centessa Pharmaceuticals PLC (CNTA), cut from its top 50 Zoetis Inc (ZTS), cut from its top 50 Netflix Inc Total (NFLX), cut from its top 50 Intercontinental Exchange in (ICE), Caterpillar Inc Com (CAT) (-47.1% shares), e.l.f. Beauty (ELF) (-37.9% shares) and Micron Technology Inc (MU) (-24.8% shares), compared with its Q1 2026 filing.

How has Platinum Investment Management Ltd's portfolio performed?

A portfolio copying Platinum Investment Management Ltd's 20 largest 13F holdings each quarter, from the day each filing was public, returned +15.8% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +31.3% against +20.1%. Over 5 years: +9.2% a year against +11.6%.

When is Platinum Investment Management Ltd's next 13F filing due?

13F filings are due 45 days after each quarter ends. Platinum Investment Management Ltd's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.